The induction of type I interferon (IFN /) is necessary for the stimulation of effective anti-viral and anti-tumor host defense. IFN can be activated by numerous pathogens and exerts multipleotropic effects through the induction of numerous genes which can invoke a cellular anti-viral effect or stimulate the activity of natural killer (NK) and dendritic cell (DC) subsets. DsRNA species are known to be inadvertent, potent inducers of type I IFN, following interaction with extracellular receptors such as toll-like receptor 3 (TLR 3). However, it has recently become apparent that TLR-independent, intracellular mechanisms of dsRNA recognition and signal transduction alternatively exist to induce type I IFN. These processes have been reported to involve FADD (Fas associated with death domain) and RIP1 (receptor interacting protein kinase 1), which are required for the activation of NF-B and IRF-3 (transcription factors necessary for the induction of IFN). The upstream cellular signaling molecules required for interacting with dsRNA and modulating the activity of FADD/RIP1 remained undefined. However, it has recently been reported that the DExD/H box RNA helicases, RIG-I (Retinoic acid inducible gene-I) and MDA5 (melanoma differentiation antigen 5) are key players in recognizing viral dsRNA species and triggering innate immune responses. Importantly, ours and others data confirm that FADD/RIP is required to facilitate DExD/H box-mediated signaling. Given this data, our objectives here are to delineate the post-translational mechanisms of innate immune signaling that appear to require FADD and RIP1 to exert innate signaling activity. Understanding how these pathways function has significant impact on understanding pathogenesis and for developing novel therapeutics and vaccines to combat disease.

Public Health Relevance

The cell has adapted to respond to pathogen infection by triggering the production of proteins which prevent infection. This proposal intends to unravel the mechanisms of anti-viral host defense, an investigation which may shed light into the causes of pathogenesis and may lead to the development of new therapeutics to combat disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA095924-06
Application #
7741854
Study Section
Developmental Therapeutics Study Section (DT)
Program Officer
Muszynski, Karen
Project Start
2002-04-01
Project End
2011-07-31
Budget Start
2009-08-20
Budget End
2010-07-31
Support Year
6
Fiscal Year
2009
Total Cost
$299,221
Indirect Cost
Name
University of Miami School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Konno, Hiroyasu; Chinn, Ivan K; Hong, Diana et al. (2018) Pro-inflammation Associated with a Gain-of-Function Mutation (R284S) in the Innate Immune Sensor STING. Cell Rep 23:1112-1123
Ahn, Jeonghyun; Xia, Tianli; Rabasa Capote, Ailem et al. (2018) Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells. Cancer Cell 33:862-873.e5
Heiber, Joshua F; Barber, Glen N (2011) Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent. J Virol 85:10440-50
Heiber, Joshua F; Xu, Xiang-Xi; Barber, Glen N (2011) Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer. Chin J Cancer 30:805-14
Elsby, Rachel; Heiber, Joshua F; Reid, Peter et al. (2011) The alpha subunit of eukaryotic initiation factor 2B (eIF2B) is required for eIF2-mediated translational suppression of vesicular stomatitis virus. J Virol 85:9716-25
Capo-chichi, Callinice D; Yeasky, Toni M; Heiber, Joshua F et al. (2010) Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models. Gynecol Oncol 116:269-75
Andrews, Nicolas P; Pack, Christopher D; Vezys, Vaiva et al. (2007) Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection. J Immunol 178:7267-75
Greidinger, Eric L; Zang, YunJuan; Jaimes, Kimberly et al. (2006) A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 54:661-9